metipranolol has been researched along with pioglitazone in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
AbuKhader, MM; Alqtaishat, S; Khanfar, MA; Taha, MO | 1 |
1 other study(ies) available for metipranolol and pioglitazone
Article | Year |
---|---|
Pharmacophore modeling, homology modeling, and in silico screening reveal mammalian target of rapamycin inhibitory activities for sotalol, glyburide, metipranolol, sulfamethizole, glipizide, and pioglitazone.
Topics: Adrenergic beta-Antagonists; Amino Acid Sequence; Anti-Infective Agents; Catalytic Domain; Crystallography, X-Ray; Glipizide; Glyburide; Humans; Hypoglycemic Agents; Metipranolol; Models, Molecular; Molecular Docking Simulation; Phosphatidylinositol 3-Kinases; Pioglitazone; Quantitative Structure-Activity Relationship; ROC Curve; Sequence Alignment; Sotalol; Sulfamethizole; Thiazolidinediones; TOR Serine-Threonine Kinases | 2013 |